SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Infleqtion, Inc. engages in delivering neutral atom solutions for quantum computing, networking, sensing, and security. Its products are categorized into computing, sensing, and cores. The company was founded on February 7, 2007, and is headquartered in Louisville, CO.

Infleqtion Inc. - Ordinary Shares - Class A

Infleqtion Inc.

Infleqtion is gaining significant market attention following an outperform initiation from Wedbush and aggressive institutional accumulation from major players like BlackRock. The community remains heavily focused on the companys strategic government contracts and its technological differentiation in quantum sensing as investors position themselves ahead of the upcoming quarterly earnings report.

XRP is a decentralized digital asset and the native token of the XRP Ledger, a Layer 1 blockchain designed for high-performance global payments. Its primary value proposition is offering a fast, cost-effective alternative to traditional banking systems by enabling near-instant cross-border settlements that finalize in three to five seconds. By serving as a neutral bridge asset between different fiat currencies, it helps financial institutions lower liquidity costs and eliminates the need for pre-funded accounts.  The network is unique because it utilizes a federated consensus protocol instead of energy-intensive mining or staking. This system achieves deterministic finality through a Unique Node List of trusted validators who must reach an eighty percent agreement threshold to permanently record transactions. This infrastructure supports a sustained throughput of 1,500 transactions per second and includes a built-in decentralized exchange that allows for the automated trading of any tokenized asset without intermediaries.  The project traces its origins back to 2004 with Ryan Fugger before being co-founded in its modern form by Jed McCaleb and Chris Larsen. The company, now known as Ripple, works with major financial institutions as partners and investors to build global payment solutions. To protect the network from spam, a small amount of XRP is burned during every transaction, and the token is further utilized by institutions as collateral to access traditional markets and manage digital asset infrastructure.  Institutional adoption of the asset reached a major milestone in November 2025 when the SEC approved the first wave of spot XRP ETFs. These products, offered by major issuers including Bitwise, Grayscale, 21Shares, Canary Capital, and Franklin Templeton, are now listed on prominent exchanges like the NYSE Arca, Nasdaq, and Cboe BZX. While Ripple remains a key contributor to the ecosystem, the underlying XRP Ledger continues to operate as an open-source and decentralized network.

Ripple

XRP is trending amid intense community debate over delayed regulatory progress and stalled legislative clarity, leading to significant polarization between long-term holders and those frustrated by stagnant price action. Investors are actively discussing the impact of political gridlock on the project's utility and speculating on potential future capital rotation into the crypto sector.

AbCellera Biologics, Inc. engages in the development of therapeutic antibodies. It offers antibody discovery platform that searches, decodes and analyzes natural immune systems to find antibodies that can be developed to prevent and treat disease. The company was founded by Carl Lars G. Hensen, Kathleen Lisaingo, Kevin Heyries, Véronique Lecault and Daniel Da Costa on November 8, 2012 and is headquartered in Vancouver, Canada.

AbCellera Biologics Inc

AbCellera Biologics is trending as investors aggressively position themselves ahead of the upcoming Phase 2 clinical readout for ABCL635, viewing it as a pivotal binary catalyst for the stock. Community sentiment is increasingly bullish, fueled by institutional accumulation, strong pharmaceutical partnerships, and high expectations for a potential rerating of the discovery engine's long-term value.

SPDR Gold Trust - SPDR Gold Shares

SPDR Gold Shares ETF

SPDR Gold Shares (GLD) is trending as investors react to a weakening U.S. dollar and cooling jobs data, which have fueled speculation about potential shifts in Federal Reserve policy. The community is actively discussing bullish sentiment driven by options activity and technical breakouts, while debating whether the metal acts as a reliable hedge against rising national debt and geopolitical instability.

United States Antimony Corp. engages in the extraction, processing and sale of antimony, zeolite, silver, and gold products. It operates through the following segments: United States Antimony Operations, Mexican Antimony Operations, Precious Metals Recovery, and United States Zeolite Operations. The company was founded by John C. Lawrence in June 1968 and is headquartered in Dallas, TX.

United States Antimony Corp.

United States Antimony Corp is trending as investors focus on its status as a critical domestic supplier amid heightened geopolitical demand and recent institutional accumulation by major firms. Community discussion highlights the stock's role in the defense supply chain, the ongoing round of industry roundtable meetings in Washington, and potential impacts of upcoming government contracts on its market position.

USA Rare Earth, Inc. is a domestic supplier of rare earth magnets and heavy rare earth elements. It develops a vertically integrated domestic supply chain for rare earth element magnet production, with a facility in Stillwater and mining rights to the Round Top heavy rare earth and critical minerals deposit in West Texas. The company was founded in May 2019 and is headquartered in Stillwater, OK.

USA Rare Earth Inc. - Ordinary Shares - Class A

USA Rare Earth Inc

USA Rare Earth is experiencing heightened community interest as investors weigh its aggressive domestic mining strategy against potential geopolitical risks and a recent leadership transition. Discussion centers on the company's efforts to secure non-Chinese supply chains, with participants actively debating the impact of upcoming production catalysts and the stability of its long-term growth plan.

Cronos is an institutional-grade, high-performance, EVM-compatible Layer-1 blockchain built on the Cosmos SDK and integrated with the Inter-Blockchain Communication (IBC) protocol, designed as the backbone for open, compliant, and AI-accessible tokenized markets. It supports up to 60,000 transactions per second (TPS), 500ms block times, instant finality, and sub-$0.01 fees via Proof of Authority consensus.

Crypto.com Coin

Investors are actively debating the potential for long-term growth versus the ongoing impact of token emissions and dilution, as interest builds around regulatory developments and the Cronos ecosystem. The community conversation remains divided, with some users highlighting native meme coin activity and institutional investment as potential catalysts, while many others express frustration over stagnant price action and past reward reductions.

Tema ETF Trust - Tema Space Innovators ETF

Tema Space Innovators ETF

The Tema Space Innovators ETF is trending as investors reassess its exposure to SpaceX following the recent IPO and strategic portfolio adjustments, including a significant conversion to Class A shares. Community sentiment remains polarized, with many debating the impact of institutional lock-ups and sector-wide volatility while seeking a long-term entry point into the evolving space infrastructure economy.

Aeva Technologies, Inc. develops sensing paradigm for autonomous vehicles and robotics. The firm offers drones, robotics, vehicle technology, and virtual and augmented reality products. The company was founded by Soroush Salehian Dardashti and Mina Rezk in 2017 and is headquartered in Mountain View, CA.

Aeva Technologies Inc

Aeva Technologies is gaining momentum as investors pivot to its role in Physical AI and optical connectivity, with recent interest fueled by its proprietary FMCW LiDAR and new semiconductor optical amplifier technology for data centers. The stock is currently a focus for those tracking AI infrastructure plays, with community discussion highlighting its strategic partnerships and the potential for a technical breakout as it moves beyond automotive-only applications.

Vertex Pharmaceuticals, Inc. is a global biotechnology company, which engages in the business of discovering, developing, manufacturing, and commercializing small molecule drugs for patients with serious diseases. The firm focuses on development and commercializing therapies for the treatment of cystic fibrosis, infectious diseases including viral infections such as influenza and bacterial infections, autoimmune diseases such as rheumatoid arthritis, cancer, inflammatory bowel disease and neurological disorders including pain and multiple sclerosis. The company was founded by Joshua S. Boger in 1989 and is headquartered in Boston, MA.

Vertex Pharmaceuticals, Inc.

Vertex Pharmaceuticals is currently drawing market attention as investors weigh the company's aggressive portfolio diversification into kidney disease and chronic pain therapies against slowing sales for its newly launched products. The community remains focused on potential M&A activity within the biotech sector and the long-term impact of the company's pipeline expansion as a growth driver beyond its core cystic fibrosis business.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

 Molson Coors Q2 Earnings Beat Estimates on Pricing and Cost Savings

TAP beats Q2 estimates as pricing and cost savings offset weaker volumes, while management reaffirms its 2026 outlook.

Monster Beverage Beats Q2 Earnings on Broad-Based Sales Growth

MNST's Q2 sales surge as energy drinks and international markets power growth, while margins improve despite rising costs.

DEO FY26 Preliminary Earnings Show Pressure on North America Weakness

Diageo's FY26 earnings show resilience with cost savings and cash gains, but North America weakness pressures sales and outlook.

Zacks Industry Outlook The Coca-Cola, Monster, Fomento, Primo and The Vita Coco 

The Coca-Cola, Monster, Fomento, Primo and The Vita Coco have been highlighted in this Industry Outlook article.

Keurig Q2 Earnings & Sales Beat Estimates on JDE Peet's Strength

KDP's Q2 earnings and sales beat estimates as JDE Peet's acquisition, U.S. Refreshment Beverages growth and efficiency initiatives lift performance.

5 Soft Drink Stocks Poised for Growth Amid Health-Focused Innovation

Healthier beverages, digital innovation and portfolio diversification continue to create opportunities for soft drinks makers. Are KO, MNST, FMX, PRMB and COCO positioned to benefit?

e.l.f. Beauty Q1 Earnings Beat on Rhode Strength, Outlook Raised

e.l.f. Beauty tops Q1 estimates as Rhode delivers $160 million in sales, international revenues jump 61%, and fiscal 2027 guidance is raised.


Ingredion Q2 Earnings Beat Estimates on T&HS Volume Growth

Ingredion beats Q2 estimates as 7% Texture & Healthful Solutions volume growth and FX gains offset Argo issues and higher costs.


SYY Q4 Earnings Beat Estimates on Volume and Cost Gains

Sysco's fiscal 2026 Q4 sales and earnings beat estimates as volume growth, brand gains and cost actions support profits.

4 Consumer Staples Stocks to Play Safe Amid Sinking Consumer Confidence

COCO, KO, WLY and CSV stand out as defensive consumer staples picks since weak consumer confidence and market volatility fuel demand for safer stocks.

$COCO Q2 '26 Earnings Results & Recap

• Reported GAAP EPS of $0.86 up 115.00% YoY
• Reported revenue of $216.15M up 28.08% YoY
• The Vita Coco Company raised its fiscal year 2026 guidance, expecting net sales between $790 million and $805 million and Adjusted EBITDA in the range of $154 million to $161 million.

The Vita Coco Co., Inc. produces, supplies and distributes coconut water. The firm offers coconut water, sparkling water, coconut milk, and oil products. It carries out its operations through its Americas and International segments. The Americas segment consists of the marketing and distribution of coconut and non-coconut water products in the US and Canada. The International segment includes the company's procurement arm and derives its revenues from the marketing and distribution of coconut water and non-coconut water products in Europe, the Middle East, and Asia Pacific. Its brands include Vita Coco, Runa, and Ever & Ever. The company was founded by Michael Kirban and Ira Liran in 2004 and is headquartered in New York, NY.

Vita Coco Company Inc (The)

Trump’s Food Tariff Cut Likely To Trim Import Costs For Hershey, Dr. Pepper, Vita Coco, Analyst Says 

Equity

Bearish Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Current Price	$62.25
Prev Close	$64.12
Open	$63.97
Dividend Yield	0.00%
50-Day Moving Average	$73.39
Beta	0.76
Avg. Volume	1.22M
PE Ratio	35.39

52-Week High	$85.83
52-Week Low	$31.92
Market Capitalization	$3.68B
EPS (Annual)	$1.19
Price to Book	9.18
Revenue Per Employee	$1.81M

Feed

News

Sentiment

Earnings

Fundamentals

Info